Characterization and first-in-human clinical dose-escalation safety evaluation of a next-gen human freeze-dried plasma.

This first next-generation FDP product preserves the potency and safety of FFP in a novel rugged, compressible, plastic container, for rapid transfusion, allowing rapid access to plasma in resuscitation protocols for therapy in acute traumatic hemorrhage.